Straits Times Index
3,084.08 -6.23 (-0.20%) S&P 500
4,594.63 +26.83 (+0.59%) Dow
36,245.50 +294.60 (+0.82%) Nasdaq
14,305.03 +78.83 (+0.55%) Bitcoin USD
41,644.34 +2,050.51 (+5.18%) CMC Crypto 200
856.74 +65.18 (+8.23%)
22nd Century Group, Inc. (XXII)
Pre-market:
| Previous close | 0.2600 |
| Open | 0.2563 |
| Bid | 0.0000 x 900 |
| Ask | 0.2679 x 800 |
| Day's range | 0.2200 - 0.2650 |
| 52-week range | 0.2010 - 18.9750 |
| Volume | |
| Avg. volume | 966,461 |
| Market cap | 8.34M |
| Beta (5Y monthly) | 1.58 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -8.7900 |
| Earnings date | 06 Nov 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 41.11 |
GlobeNewswire22nd Century Secures $3.2 Million to Date in Warrant Exchange Transaction
Newly Appointed CEO Leading Restructuring to Focus on Tobacco Industry Operations, Reduce CostsBUFFALO, N.Y., Dec. 04, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company”), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced the exercise of warrants by certain holders pursuant to its previously announced warrant inducement offering. During the inducement period, certain holders of the Company’s exist
- GlobeNewswire
22nd Century Appoints Larry Firestone as Chairman and CEO
Turnaround Veteran to Focus on Unlocking Shareholder Value in Tobacco AssetsBUFFALO, N.Y., Nov. 29, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (“22nd Century” or the “Company”), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced the appointment of Lawrence (Larry) Firestone as the Company's Chairman and Chief Executive Officer. Nora Sullivan, former Chair of the Board, commented, “Larry is a seasoned exec
- GlobeNewswire
22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise
Sale Expected to Result in Immediate and Significant Reduction in Operating Costs and Cash RequirementsBUFFALO, N.Y., Nov. 27, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company” or “22nd Century”), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced it has reached an agreement to sell substantially all of its GVB Biopharma (“GVB”) hemp/cannabis operations to Specialty Acquisition Corporation
